| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/12/2005 | CA2544473A1 A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof |
| 05/12/2005 | CA2544372A1 A pharmaceutical composition for preventing or treating malignant glioma |
| 05/12/2005 | CA2544365A1 Modified anti-cd52 antibody |
| 05/12/2005 | CA2544335A1 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 05/12/2005 | CA2544297A1 Use of 2-thia-dibenzo[e, h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 05/12/2005 | CA2544267A1 Thiazolidinones, production and use thereof as medicaments |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2542904A1 Iap nucleobase oligomers and oligomeric complexes and uses thereof |
| 05/12/2005 | CA2542884A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent |
| 05/12/2005 | CA2541856A1 Modified polypeptides with therapeutic activity and methods of use |
| 05/12/2005 | CA2541846A1 A protein involved in ovarian cancer |
| 05/12/2005 | CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 05/12/2005 | CA2448995A1 Device and method for attracting diseased cells and foreign substances |
| 05/11/2005 | EP1529777A2 Process and oxazolidine intermediate for the synthesis of taxanes |
| 05/11/2005 | EP1529527A2 Valproic acid for a combination treatment of human cancers, tumor metastasis and minimal residual disease |
| 05/11/2005 | EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 05/11/2005 | EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 05/11/2005 | EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/11/2005 | EP1529048A2 Methods for the synthesis of substituted purines |
| 05/11/2005 | EP1529047A2 New purine derivatives |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 05/11/2005 | EP1528936A1 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer |
| 05/11/2005 | EP1528934A1 Use of antibodies against a tumor-associated antigen |
| 05/11/2005 | EP1528928A2 Methods and compositions for modulating beta-catenin phosphorylation |
| 05/11/2005 | EP1528925A1 Quinazoline derivatives for use in the treatment of cancer |
| 05/11/2005 | EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/11/2005 | EP1528909A1 Trihydroxy polyunsaturated eicosanoids |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1315480B1 "slow release" pharmaceutical compositions comprising lithium carbonate |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP1257526B1 Aniline-derived ligands for the thyroid receptor |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1177790B1 Therapy with cannabinoids in the treatment of cerebral tumor |
| 05/11/2005 | EP1105738B1 Assays for modulating nuclear localisation |
| 05/11/2005 | EP1088069B1 Angiostatin-binding protein |
| 05/11/2005 | EP1068224B1 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/11/2005 | EP0987943B1 Detecting and treating cancer |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0625200B1 Biosynthetic binding protein for cancer marker |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615315A Tumor specific monoclonal antibodies |
| 05/11/2005 | CN1615306A C-5 modified indazolylpyrrolotriazines |
| 05/11/2005 | CN1615300A Benzimidazole derivatives and their use as GNRH antagonists |
| 05/11/2005 | CN1615155A Anti-proliferative composition |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615147A Treatment of glioblastoma with thymosin-alpha 1 |
| 05/11/2005 | CN1615136A Combinations comprising epothilones and anti-metabolites |
| 05/11/2005 | CN1615131A Method for identification of tumor targeting enzymes |
| 05/11/2005 | CN1615130A Taxane based compositions and methods of use |
| 05/11/2005 | CN1615129A Process for affecting neurologic progression |
| 05/11/2005 | CN1615127A Substituted bicyclo[3.3.1]nonan-2, 4, 9-triones as pharmaceutical active ingredients |
| 05/11/2005 | CN1615122A Pharmaceutical formulation comprising bicalutamide |
| 05/11/2005 | CN1614027A Polytheneimine transgened carrier of targeted fibroblast growth factor receptor |
| 05/11/2005 | CN1613876A Three spiral lentinan with anti-cancer activity and its preparation and use |
| 05/11/2005 | CN1613867A Antineoplastic comound, Preparation and medicine composition with compound as active ingredient |
| 05/11/2005 | CN1613865A Trans-oligonucleotide, medicinal composition containing it and use thereof |
| 05/11/2005 | CN1613862A Adriacin derivative with anti-cancer activity |
| 05/11/2005 | CN1613844A Chiral 1, 4 diamidogen and its complex of platinum II |
| 05/11/2005 | CN1613481A Chinese patent drug for treating female ovarian cyst and its preparation |
| 05/11/2005 | CN1613476A Chinese medicine for treating liver diseases |
| 05/11/2005 | CN1613475A Chinese medicine for treating liver diseases |
| 05/11/2005 | CN1613466A Paste for treating cancers |
| 05/11/2005 | CN1613462A Longhedan pills and their preparation |
| 05/11/2005 | CN1613461A Arthralgia removing pills and their preparation |
| 05/11/2005 | CN1613456A Freezing dried mycobatctericsis preparation and its preparing method and use |
| 05/11/2005 | CN1613455A Targeting microorgan micro-capsules and their preparation |
| 05/11/2005 | CN1201006C High-affinity interleukin-4 muteins |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/11/2005 | CN1201004C HER-2/neu fusion proteins |
| 05/11/2005 | CN1200951C Process for productio nof multiple cross-linked hyaluronic acid derivatives |
| 05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
| 05/11/2005 | CN1200947C Method for producing cyclo-(Asp-Dphe-NMeVal-Arg-Gly) |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 05/11/2005 | CN1200734C Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 05/11/2005 | CN1200727C Pharmaceutical compositions based on alpha-cyclodextrin for oral administratio nof LH-RH analogues |
| 05/11/2005 | CN1200726C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/11/2005 | CN1200716C Antineoplastic |
| 05/11/2005 | CN1200714C Use of diterpenoid triepoxides as anti-proliferative agent |
| 05/11/2005 | CN1200712C Combination comprising camptothecin and stilbene derivative for treatment of cancer |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |
| 05/11/2005 | CA2479696A1 Use of calphostin-c to treat drug-sensitive tumor cells |
| 05/10/2005 | US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 05/10/2005 | US6891062 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6890949 Amino ceramide-like compounds and therapeutic methods of use |
| 05/10/2005 | US6890948 With an electron withdrawing substituent; Treating neoplastic diseases in methods of GDEPT, ADPET, PDEPT, VDEPT, and PDT; tissue-directed prodrug therapy |
| 05/10/2005 | US6890943 3-acylated pyridoxal derivatives used to treat vitamin B6 deficiency, cardiovascular diseases, melanoma and other related diseases |
| 05/10/2005 | US6890938 Antiinflammatory agents |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890929 Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 05/10/2005 | US6890926 Antitumor agents |
| 05/10/2005 | US6890924 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 05/10/2005 | US6890917 Particularly significant oral in vivo activity |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |